NGM Biopharmaceuticals (NGM) Reports Q3 Loss, Misses Revenue Estimates

Published on 16 Nov 2023 on Zacks · via Yahoo Finance

NGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of 12.50% and 67.67%,...

Read the rest of the article

Start tracking your investments with Statfolio

NGM Biopharmaceuticals (NGM) came out with a quarterly loss of $0.33 per share versus the Zacks C...

Zacks · via Yahoo Finance 19 Mar 2024

Jin-Long Chen knows the biotech cycle of life, maybe too well. Chen last year left NGM ...

The Business Journals 12 Mar 2024

Affiliates of NGM Biopharmaceuticals Inc. earliest venture capital backer and its largest current...

The Business Journals 26 Feb 2024

Shares of Freshpet, Inc. FRPT gained 15.5% to $106.29 after the company reported better-than-exp...

Benzinga 26 Feb 2024

NGM Biopharmaceuticals , Inc. (NASDAQ: NGM ), a biotech firm engaged in developing transformative...

Investing.com 25 Feb 2024

Investors are always looking for stocks that are poised to beat at earnings season and NGM Biopha...

Zacks · via Yahoo Finance 17 Feb 2024

Key Insights Given the large stake in the stock by institutions, NGM Biopharmaceuticals' stock pr...

Simply Wall St. via Yahoo Finance 3 Jan 2024

NGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of 12.50% and 67.67%,...

Zacks · via Yahoo Finance 16 Nov 2023

NGM Biopharmaceuticals Inc (NASDAQ:NGM) reported a net loss of $28.8 million for Q3 2023, compare...

GuruFocus.com via Yahoo Finance 3 Nov 2023

Insiders who acquired US$462k worth of NGM Biopharmaceuticals, Inc.'s (NASDAQ:NGM) stock at an av...

Simply Wall St. via Yahoo Finance 24 Sep 2023